FOMAT

Plasmodium antibodies

Research Suggests New Vaccine Candidates for Malaria

Researchers have shown that higher levels of Plasmodium antibodies are protective against severe malaria in children living in Papua New Guinea. Children who have higher levels of antibodies to a specific short amino acid sequence in the malaria parasite, P. falciparum,…

Read More
180703 parkinsons

Experimental Drug Stops Parkinson’s Disease in Mice

Johns Hopkins researchers say they have developed an experimental drug, similar to compounds used to treat diabetes, that slows the progression of Parkinson’s disease itself — as well as its symptoms — in mice. In experiments performed with cultures of human…

Read More
World cancer day (February 4). Woman hand holding Lavender purpl

Lupus Treatment Generates Positive Results in Phase III Clinical Trial

New research indicates that belimumab, a monoclonal antibody therapy that targets a component of the immune system, provides considerable benefits to patients with systemic lupus erythematosus (SLE), a predominately female, chronic inflammatory disease that can affect virtually any organ. The Arthritis &…

Read More
Tumor immunity

Personalized Tumor Vaccine Shows Promise in Pilot Trial

A new type of cancer vaccine harnesses tumor immunity has yielded promising results in an initial clinical trial conducted at the Perelman School of Medicine at the University of Pennsylvania and the Abramson Cancer Center of the University of Pennsylvania. The…

Read More
Clinical Research Services

FOMAT Medical Research Announces Joint Venture with the Hospital Teodoro Maldonado Carbo

FOMAT Medical Research, a pioneering clinical research company in Latin America, is honored to announce that it will embark on a joint venture with the hospital Teodoro Maldonado Carbo in Ecuador in order to provide clinical research services in the South…

Read More
FOMAT joins forces with Reumalab.

FOMAT Medical Research Announces Joint Venture with Reumalab

Oxnard, CA, December 2017 – FOMAT Medical Research, a leading organization in clinical research, is launching a joint venture with Reumalab in order to provide clinical research services in Medellin, Colombia, that is set to improve clinical research outcomes in Latin…

Read More
boost minority participation

5 ways to boost Minorities’ Participation in Clinical Trials

Minorities’ participation in clinical trials is often an issue of debate among the clinical research industry. Anyway, most of us agree that their participation is crucial in order to develop better treatments for everybody.  That’s why as part of the professionals…

Read More
Heart disease prevention

Hispanics and Diabetes Clinical Studies

Hispanics and Diabetes People with Hispanic or Latino backgrounds are at higher risk for developing type 2 diabetes than non-Hispanic Caucasians. This is a fact that researchers have long known. However, most research has looked at this group as a whole,…

Read More
Clinical Trials Diversity

Why diversity in Clinical trials is important?

Understanding the issue Clinical trials are the key to find and learn about the consequences of new medical treatments in people’s well-being. Some of them focus on patient’s safety and treatment effectiveness, others are just observational. These treatments include medicines, medical…

Read More